Please Login to read the full article.
Clinica
St Jude's neuromodulator fails in migraine trial – US approval unlikely?
23 June 2011
Elizabeth Cairns
Please Login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- Quarterly results round-up: St Jude and Quest cut jobs to rein in costs, Baxter strong again
- Stryker’s Wingspan clipped by study showing higher stroke risk versus drug therapy
- Edwards' Sapien TAVI device closer to US approval with positive FDA report
- St Jude's Unify and Fortify CRM devices hit Japan
Other Informa News
